Metabolic Health
Metformin
Explore a prescription option used in metabolic and longevity care plans.
Read More →Provider-guided, low-dose intermittent rapamycin (sirolimus) for adults exploring evidence-informed healthspan protocols.

Rapamycin, also known as sirolimus, inhibits mTORC1 — a central regulator of cell growth, protein synthesis, and autophagy. At low, intermittent doses it is studied for autophagy, inflammation, and healthspan rather than the continuous suppression used in transplant protocols.
Elevate My Care offers a provider-guided telehealth process for adults interested in exploring whether low-dose rapamycin may be appropriate for their individual health goals.
Inhibits mTORC1, a central regulator of cellular growth studied in longevity medicine.
mTOR suppression is associated with autophagy — the body's clearing of damaged proteins and organelles.
At low doses, studied for immune regulation and reduced chronic low-grade inflammation.
Progress is followed through inflammatory and metabolic markers rather than short-term change.
Share your health history, medications, goals, and relevant medical information through a secure online questionnaire.
A licensed provider reviews your information and determines whether treatment may be medically appropriate.
If prescribed, receive your treatment instructions, supplies, and next steps.
Continue receiving provider support and access to educational resources throughout your treatment journey.
Rapamycin is taken orally, typically once weekly at low dose. Dosage, frequency, administration instructions, and treatment duration should follow the individualized directions provided by your licensed provider.
Provider-guided, low-dose intermittent rapamycin (sirolimus) for adults exploring evidence-informed healthspan protocols.
See pricing & plansTreatment eligibility and final prescription are determined by a licensed provider.